在使用皮下药物治疗的硬化症生命末期的胃肠道症状的社区管理:一个病例报告
Amanda Landers1, Rebecca Davey2, Hamish Farquhar3
1Department of Medicine, University of Otago, Christchurch, New Zealand; Hospice Southland, Southland, New Zealand.
Annals of palliative medicine
|March 11, 2026
概括
皮下使用的欧梅普拉在终身系统性硬化症患者中有效地控制了严重的胃肠道症状. 这种方法允许在家进行息治疗,在口服药物失败时尊重患者的愿望.
科学领域:
- 抚慰性护理是一种缓解性护理.
- 胃肠病学 胃肠病学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 系统性硬化症 (SSc) 经常导致严重的胃肠道问题.
- 在临终期临近的家庭中对这些症状进行管理是具有挑战性的,特别是无法服用口服药物.
- 住院可能与患者生命末期的偏好发生冲突.
研究的目的:
- 描述在社区环境中使用皮下注射欧米的情况.
- 在先进的SSc患者中管理难治的上部胃肠道症状.
- 探索一种替代对肠道药物治疗和住院治疗的替代方案.
主要方法:
- 一个持续的皮下输注奥梅普拉给了一个患有晚期SSc.的患者.
- 患者经历了耐火的上部胃肠道症状,包括反流和血.
- 选择药物途径是基于患者的偏好和口服摄入的不可靠性.
主要成果:
- 患者报告说,随着皮下输注奥梅普拉,症状显著改善.
- 症状在降低剂量后复发,在增加剂量后改善,表明有效性.
- 这种方法允许患者留在家中.
结论:
- 皮下使用的欧梅普拉可以安全有效地用于社区的终末消化肠道症状管理.
- 灵活的处方和个性化护理对于尊重患者偏好至关重要.
- 病例报告对于为息治疗研究中的临床实践提供信息至关重要.
相关概念视频
01:29Inflammatory Bowel Disease IV: Pharmacological Management
883
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
883
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
957
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
957
01:29Chronic Pancreatitis II: Collaborative Care
452
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
452
01:26Peptic Ulcer Disease IV: Management
601
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
601
01:24Nephrotic Syndrome III : Nursing Management
410
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
410
01:20Myasthenia Gravis: Overview and Treatment
3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K